Back to Journals » Vascular Health and Risk Management » Volume 8

Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action

Authors Al-Omran M

Received 9 April 2012

Accepted for publication 20 April 2012

Published 28 May 2012 Volume 2012:8 Pages 349—355

DOI https://doi.org/10.2147/VHRM.S32783

Review by Single-blind

Peer reviewer comments 2

Mohammed Al-Omran
The Peripheral Vascular Disease Research Chair and Division of Vascular Surgery, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Purpose: Atherosclerotic disease (AD) is the leading cause of death worldwide and in Saudi Arabia. Intensive risk reduction therapy plays a major role in reducing adverse cardiovascular outcomes in patients with AD. The level of awareness of this important fact amongst physicians (family physicians, general internists, cardiologists and vascular surgeons) in managing these patients in Saudi Arabia is not currently known. This study was conducted to examine the perceptions and knowledge of risk reduction therapy in patients with AD amongst physicians in Saudi Arabia in two clinical presentations; coronary artery disease (CAD) and peripheral artery disease (PAD).
Materials and methods: We conducted a cross-sectional self-administered survey of 897 physicians at different hospitals in four provinces in Saudi Arabia.
Results: The recommended targets of low density lipoprotein-cholesterol (LDL-C), blood glucose, and blood pressure in patients with CAD and PAD were known as 40% and 36%; 70% and 66%; and 32% and 28% of physicians, respectively. The initiation of antiplatelet medications, angiotensin converting enzyme (ACE) inhibitors, statins, and nicotine replacement therapy for smokers in patients with CAD and PAD were recommended by 98% and 97%; 52% and 34%; 61% and 56%; and 50% and 43% of physicians, respectively. Compared to other specialties, cardiologists had the lowest threshold for initiating risk reduction therapy, whereas vascular surgeons had the highest threshold.
Conclusion: The level of physician awareness of atherosclerosis risk reduction therapy across Saudi Arabia has revealed knowledge and action gaps. A call to action to implement effective strategies to encourage health professionals to use risk reduction therapy and increase public awareness is needed.

Keywords: coronary artery disease, peripheral arterial disease, risk reduction, atherosclerosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

The MGuard coronary stent: safety, efficacy, and clinical utility

Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A

Vascular Health and Risk Management 2015, 11:533-539

Published Date: 18 September 2015

Assessing the risk of recurrent venous thromboembolism – a practical approach

Fahrni J, Husmann M, Gretener SB, Keo HH

Vascular Health and Risk Management 2015, 11:451-459

Published Date: 17 August 2015

Blood pressure control to prevent decline in cognition after stroke

Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B

Vascular Health and Risk Management 2015, 11:311-316

Published Date: 9 June 2015

The prevention and regression of atherosclerotic plaques: emerging treatments

Kalanuria AA, Nyquist P, Ling G

Vascular Health and Risk Management 2012, 8:549-561

Published Date: 25 September 2012

Use of carvedilol in hypertension: an update

Leonetti G, Egan CG

Vascular Health and Risk Management 2012, 8:307-322

Published Date: 18 May 2012